Skip to content
TrialScanner

NCT03372902

Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening

No phase registeredCompletedGRALCollaborator

Registry record

Lead sponsor
Memorial Sloan Kettering Cancer Center
Conditions
Breast Cancer; Breast Benign
Primary completion
Mar 12, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03372902 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03372902: Development Of A Blood Test... | TrialScanner